Delivery Order SPE2DB20D2001-SPE2DB23FM49L
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $1,023.38, is a delivery order contract for the supply of 4565668171 LATUDA 20 MG TABLET 30S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of September 4, 2024. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,233.27 firm fixed-price delivery order covers the supply of 80 mg Latuda tablets to support military healthcare programs. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the delivery of Latuda 40 mg tablets, a specialty pharmaceutical product, with a ceiling value of $2,035.74 and a performance period through April 2, 2024. This award is a delivery order contract, with a firm fixed price pricing type, and does not have a set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Latuda 20 mg tablets. The contract has a ceiling value of $3,534.45 and an ultimate completion date of September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and other federal healthcare providers. The contract is not set aside for any specific business...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $11,689.31, is for the delivery of LATUDA 20 MG TABLET 30S, a medication, under a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $2,088.28 for the supply of Latuda 20mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,355.41 Firm Fixed Price Delivery Order is for the supply of 4565048943 LATUDA 60 MG TABLET 30S, a prescription medication. The contract has no set-aside designation and has an ultimate completion date of July 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,092.75 firm fixed price delivery order is for the supply of 4563430806 - LATUDA 20 MG TABLET 30S. The contract has a completion date of January 25, 2024 and was awarded on January 24, 2024. No set-aside designation was used for this award. Amerisourcebergen...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557906066 - LATUDA 40 MG TABLET 30S. The $3,021.95 firm fixed-price delivery order contract has a completion date of July 27, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM49LDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,037.29 firm fixed-price delivery order is for the supply of Latuda 20 mg tablets. The contract has an ultimate completion date of April 14, 2023 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.0k | 4/13/23 |